Acquisition or Collaboration Finder Services Sample Clauses

Acquisition or Collaboration Finder Services. Except with respect to parties specified in an exhibit attached to this Agreement, if an Acquisition or Collaboration is consummated by G/O during the term of this Agreement or for a period of three year thereafter, provided such Acquisition or Collaboration involves a party identified by Consultant during the term of this Agreement, G/O will pay to Consultant a Finder's Fee based on the following formula: Finder's Fee Rate Transaction Value 15% of the portion below $9,999,999 plus 12% of the portion from $10,000,00 to $19,999,999 plus 10% of the portion from $20,000,000 to $29,999,999 plus 8% of the portion from $30,000,000 to $39,999,999 plus 6% of the portion from $40,000,000 to $49,999,999 plus 4% of the portion over $50,000,000 The Transaction Value represents the total value agreed to among the parties to the transaction and will include any combination of equity securities, net assets, goodwill, consulting fees, noncompetitive agreements, equity or debt investments, royalties or any other form of payment, whether contingent or firm. Any issuance of registered securities, in connection with the transaction, would be valued at the closing public bid price of such securities on the date of the closing the transaction. Any unregistered securities that were issued with restrictive legends would be valued at 50% of the closing public asked price of such class of securities on the date of closing the transactions, or at such greater value as may be recorded for accounting purposes in accordance with generally accepted accounting principles. If Consultant and the Company disagree as to the Transaction Value of any transaction, a Transaction Value shall be determined by an independent appraisal performed at the mutual expense of Consultant and G/O by an independent appraiser selected by Consultant and approved by the Company. If the Finder's Fee includes Transaction Value amounts which are contingent upon future event(s), such Finder's Fee will be paid either on the date such contingent amounts are paid or on such earlier date that the contingent amounts become fixed in value. If, however, the Transaction Value amount shall not be contingent upon future events, but the consideration tendered in such transaction shall not be paid in full at the consummation of such transaction, Consultant shall receive payment within ten days after each date on which any part of such consideration is paid or received by G/O or any of it subsidiaries or affiliates in amounts e...
Sample 1
AutoNDA by SimpleDocs

Related to Acquisition or Collaboration Finder Services

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Development Services Licensee may from time to time wish to augment the RMSS product with additional functionality or utility, or to integrate it with Licensee systems from other sources, and for such purposes may request the provision of development services from RMSS.

  • Support Services Other than the assistance provided in the Information, the BNPP Entities do not offer any support services in connection with the Software.

  • Exclusivity of Services The Subadviser shall devote its best efforts and such time as it deems necessary to provide prompt and expert service to Client and the Fund. The services of Subadviser to be provided hereunder are not to be deemed exclusive and Subadviser shall be free to provide similar services for its own account and the accounts of other persons and to receive compensation for such services. Client acknowledges that Subadviser and its Affiliates and Subadviser's other clients may at any time, have, acquire, increase, decrease or dispose of positions in the same investments which are at the same time being held, acquired for or disposed of under this Agreement for the Fund. Subadviser shall have no obligation to acquire or dispose of a position in any investment pursuant to this Agreement simply because Subadviser, its directors, members, Affiliates or employees invest in such a position for its or their own accounts or for the account of another client.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • Services to Other Clients; Certain Affiliated Activities (a) The relationship between the Asset Manager and the Series is as described in this Agreement and nothing in this Agreement, none of the services to be provided pursuant to this Agreement, nor any other matter, shall oblige the Asset Manager to accept responsibilities that are more extensive than those set forth in this Agreement.

  • Collaboration Management Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Commercialization Reports After the First Commercial Sale of a Licensed Product anywhere in the Territory, LICENSEE shall submit to Cornell semi-annual reports on or before each February 28 and August 31 of each year. Each report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar half-year and shall show:

  • Acquisition Services (i) Serve as the Company’s investment and financial advisor and provide relevant market research and economic and statistical data in connection with the Company’s assets and investment objectives and policies;

Time is Money Join Law Insider Premium to draft better contracts faster.